Contrast-enhanced mammography in the management of breast architectural distortions and avoidance of unnecessary biopsies
- PMID: 38811515
- DOI: 10.1007/s12282-024-01599-x
Contrast-enhanced mammography in the management of breast architectural distortions and avoidance of unnecessary biopsies
Abstract
Background: To assess contrast-enhanced mammography (CEM) in the management of BI-RADS3 breast architectural distortions (AD) in digital breast tomosynthesis (DBT).
Methods: We retrospectively reviewed 328 women with 332 ADs detected on DBT between 2017 and 2021 and selected those classified as BI-RADS3 receiving CEM as problem-solving. In CEM recombined images, we evaluated AD's contrast enhancement (CE) according to its presence/absence, type, and size. AD with enhancement underwent imaging-guided biopsy while AD without enhancement follow-up or biopsy if detected in high/intermediate-risk women.
Results: AD with enhancement were 174 (52.4%): 72 (41.4%) were malignant lesions, 102 (59.6%) false positive results: 28 (16%) B3 lesions, and 74 (42.5%) benign lesions. AD without enhancement were 158 (47.6%): 26 (16.5%) were subjected to biopsy (1 malignant and 25 benign) while the other 132 cases were sent to imaging follow-up, still negative after two years. CEM's sensitivity, specificity, positive (PPV) and negative predictive values (NPV), and accuracy were 98.63%, 60.62%, 41.38%, 99.37%, and 68.98%. The AUC determined by ROC was 0.796 (95% CI, 0.749-0.844).
Conclusion: CEM has high sensitivity and NPV in evaluating BI-RADS3 AD and can be a complementary tool in assessing AD, avoiding unnecessary biopsies without compromising cancer detection.
Keywords: Breast cancer; CEM; Distortions.
© 2024. The Author(s), under exclusive licence to The Japanese Breast Cancer Society.
Similar articles
-
Value of contrast-enhanced mammography combined with the Kaiser score for clinical decision-making regarding tomosynthesis BI-RADS 4A lesions.Eur Radiol. 2022 Nov;32(11):7439-7447. doi: 10.1007/s00330-022-08810-7. Epub 2022 May 31. Eur Radiol. 2022. PMID: 35639141
-
Clinical utility of contrast-enhanced spectral mammography as an adjunct for tomosynthesis-detected architectural distortion.Clin Imaging. 2017 Nov-Dec;46:44-52. doi: 10.1016/j.clinimag.2017.07.003. Epub 2017 Jul 12. Clin Imaging. 2017. PMID: 28723585
-
Tomosynthesis-Guided Vacuum-Assisted Breast Biopsy of Architectural Distortion Without a Sonographic Correlate: A Retrospective Review.AJR Am J Roentgenol. 2021 Oct;217(4):845-854. doi: 10.2214/AJR.20.24740. Epub 2020 Nov 4. AJR Am J Roentgenol. 2021. PMID: 33147055
-
Evaluation of architectural distortion with contrast-enhanced mammography.Clin Radiol. 2024 Mar;79(3):163-169. doi: 10.1016/j.crad.2023.11.021. Epub 2023 Dec 10. Clin Radiol. 2024. PMID: 38114374 Review.
-
Malignant Outcomes of Architectural Distortion on Tomosynthesis: A Systematic Review and Meta-Analysis.AJR Am J Roentgenol. 2021 Aug;217(2):295-303. doi: 10.2214/AJR.20.23935. Epub 2020 Sep 23. AJR Am J Roentgenol. 2021. PMID: 32966111
Cited by
-
Lesion Conspicuity in Contrast-Enhanced Mammography: A Retrospective Analysis of Tumor Characteristics.Cancers (Basel). 2025 Feb 3;17(3):501. doi: 10.3390/cancers17030501. Cancers (Basel). 2025. PMID: 39941868 Free PMC article.
References
-
- Breast Imaging Reporting & Data System. https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/Bi-Rads . Accessed 27 Jan 2020.
-
- Gaur S, Dialani V, Slanetz PJ, Eisenberg RL. Architectural distortion of the breast. Am J Roentgenol. 2013;201:W662–70. https://doi.org/10.2214/AJR.12.10153 . - DOI
-
- Si L, Zhai R, Liu X, et al. MRI in the differential diagnosis of primary architectural distortion detected by mammography. Diagn Interv Radiol. 2016;22:141–50. https://doi.org/10.5152/dir.2016.15017 . - DOI - PubMed - PMC
-
- Partyka L, Lourenco AP, Mainiero MB. Detection of mammographically occult architectural distortion on digital breast tomosynthesis screening: initial clinical experience. AJR Am J Roentgenol. 2014;203:216–22. https://doi.org/10.2214/AJR.13.11047 . - DOI - PubMed
-
- Ciatto S, Houssami N, Bernardi D, et al. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study. Lancet Oncol. 2013;14:583–9. https://doi.org/10.1016/S1470-2045(13)70134-7 . - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical